BioNTech SE logo

Executive Director, Clinical Development

BioNTech SE
Remote friendly (Cambridge, MA)
United States
$245,000 - $400,000 USD yearly
Clinical Research and Development

Role Summary

Location: Cambridge, US; Gaithersburg, US; New Jersey, US. As Executive Director Clinical Development, you will lead the strategic direction and operationalization of clinical development for assigned programs, guiding trials from early to late-stage development through regulatory approval. You will collaborate with multidisciplinary teams globally to drive innovation, ensure patient safety, and uphold data integrity.

Responsibilities

  • Lead and manage a team of medical professionals representing Clinical Development within global teams, including Core Teams, Project Teams, and Study Teams.
  • Oversee the design and execution of clinical trials, ensuring alignment with strategic goals and regulatory requirements.
  • Supervise the creation of integrated evidence generation plans paving paths toward regulatory approval.
  • Represent BioNTech in collaborations with industry partners, academic investigators, advisory meetings with opinion leaders, and interactions with Health Authorities.
  • Provide medical expertise across functions such as business development, discovery, non-clinical development, medical communications, quality assurance, clinical operations, biostatistics, regulatory affairs, and drug safety.

Qualifications

  • Experience: Minimum of 8+ years of relevant clinical R&D experience within Immuno-Oncology, Oncology, and/or Infectious Diseases at biotech/pharmaceutical and academic settings at an international level, including leading development programs from exploratory Phase I/II through Phase III and NDA submission.
  • Thorough understanding of clinical and scientific methods and approaches used in clinical development, including novel study designs, application of companion diagnostics for patient selection, clinical pharmacology/translational modeling, and biostatistics; plus experience with confirmatory Phase III trial design and dossier submission.
  • Global health authority interactions (EMA, FDA, CDE). Participation or leadership in a drug development program that achieved successful registration is an advantage.
  • Strong medical experience in overseeing and interpreting safety and efficacy data and ensuring appropriate contact for study medical and patient safety aspects.
  • Demonstrated leadership as a program lead with several years (greater than 4) of line management experience in a global matrix organization. Ability to lead horizontally and drive execution of workplans in collaboration with other functions, without having formal line management authority.
  • Proficiency in English (written and spoken).

Education

  • Medical Doctor (MD) with a strong scientific background in Immuno-Oncology, Oncology, or Infectious Diseases.